Introduction {#Sec1}
============

Orexin A (OXA) is produced by a small group of neurons specifically located within and around the lateral hypothalamus (LH) (de Lecea et al. [@CR7]). Like OXB, OXA is a neuropeptide encoded by mRNA which accumulates primarily after the third postnatal week (Gautvik et al. [@CR12]). OXA is a 33-amino acid peptide, the sequence of which is identical in human, rat, mouse, and bovine (Sakurai et al. [@CR29]). Experiments with synaptically coupled rat hypothalamic neurons, demonstrate that Orexin acts as an excitatory neurotransmitter with two specific receptors (de Lecea et al. [@CR7]), Orexin Receptor-1 (OR1) and Orexin Receptor-2 (OR2), which belong to the G-protein coupled receptor superfamily (Sakurai et al. [@CR29]). These receptors share 64% identity in their amino acid sequence and exhibit marked differential distribution. OXA is a selective ligand for OR1. In contrast to orexinergic neurons, the presence of ORs is not restricted to the hypothalamus. Both OR types have a high level of expression in multiple brain regions (Trivedi et al. [@CR36]) and thus orexins may orchestrate a large number of processes in the nervous system (Fadel et al. [@CR9]).

It is widely assumed that deteriorated cognitive processes are related to impaired network connectivity and activity. Conversely, several neurodegenerative diseases that lead to deteriorated cognitive abilities have been related to OXA deficiency. Both the number of orexinergic neurons in the hypothalamus and the levels of orexin in the cerebrospinal fluid are reduced by 72% in the end-stage in a mouse model of Huntington's disease (Petersén et al. [@CR25]). Recent studies in Parkinson's patients found a 40% lower OXA concentration in the frontal cortex and a 25% reduction in the cerebrospinal fluid (Fronczek et al. [@CR11]). These findings suggest that orexin may influence network connectivity and activity.

Experiments in vivo (Peever et al. [@CR24]) and in vitro with acute application of the transmitter on organotypic brain slices (Horvath et al. [@CR14]) or dissociated neuronal cultures (Stoyanova et al. [@CR35]) indicated that OXA has an excitatory effect on network activity. However, the effects of OXA on cortical development remain unclear, in particular the effect on synaptogenesis.

It has been shown that synaptic formation responds to various inputs. For instance, Horvath and Gao ([@CR13]) demonstrated synaptic re-organization in orexinergic neurons in vivo after glucose deficiency, but detailed data about the synaptogenesis is not easy to acquire in vivo. Furthermore, it is very difficult to quantify orexinergic input to the cortex in vivo. Therefore, we used cultures of dissociated cortical neurons to investigate the effects of OXA on synaptogenesis in a controlled study.

Dissociated cortical neurons have been shown to form networks and to become spontaneously active after approximately a week (Van Pelt et al. [@CR41]; Chiappalone et al. [@CR2]). We designed experiments with two groups of networks: one incubated in plain medium, and the other in medium chronically supplemented with OXA. Immunostaining for OR1 was applied in order to determine at what developmental stage the receptor is expressed and neurons could react to the OXA application. To quantify the alterations in network formation we combined it with immunocytochemistry for detection of OXA and synaptic marker synaptophysin during the first 4 weeks of development in vitro.

Materials and Methods {#Sec2}
=====================

Dissociated Cell Cultures {#Sec3}
-------------------------

Newborn Wistar rats were anesthetized with ether and decapitated. The brains were removed and placed in RPMI-medium. The meninges were removed; the cortices were dissociated and collected in chemically defined R12 culture medium (Romijn et al. [@CR28]) with trypsin for chemical dissociation. After the trypsin, 150 μl of soybean trypsin inhibitor and 125 μl of DNAse I (20.000 units, Life Technology) were added, followed by mechanical dissociation of the neurons. The suspension was centrifuged at 1200 rpm for 5 min; the pellet was plated on glass cover slips pre-coated with 20 mg/ml poly-ethylene-imine (Fluka, Buchs, Switzerland), at a density of approximately 3000 cells/mm^2^. They were allowed to attach for 2 h at 37°C and 5% CO~2~ in air and kept in R12 medium optimized with 50 ng/ml nerve growth factor (Invitrogen, Carlsbad, CA). Medium was serum-free to suppress glial cell proliferation and keep their concentration lower than 5% (Romijn et al. [@CR28]). It was renewed every 2--3 days. For assessment of the effect of OXA on synaptogenesis 2 μM OXA was added to the medium. We use this concentration because it has been shown that it produces measurable changes in neuronal activity (Horvath et al. [@CR14]). Cultures were fixed in 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS), pH 7.4 after 1, 4, 7, 14 or 21 DIV, and processed for immuno-detection of OXA, OR1, or synaptophysin. For identification of the cellular type we applied specific markers, i.e., anti-Microtubule Associated Protein (MAP2) antibody as a neuronal marker and anti-Glial Fibrillary Acidic Protein (GFAP) antibody, a marker for glial cells.

Animals and Tissue Preparation {#Sec4}
------------------------------

Adult Wistar rats (250--359 g body weight) were used as a positive control for testing specificity of anti-OXA antibody. All housing facilities and procedures used were approved by the Animal Care and Use Committee of the University of Twente, and were carried out in accordance with the European Communities Council Directive of 24 November 1986. The rats were anesthetized and perfused with 4% paraformaldehyde in 0.1 M PBS (pH 7.4). The brains were removed, postfixed by immersion in the same fixative for 24 h at 4°C and cryoprotected in 25% sucrose in PBS at 4°C. They were embedded in TissueTek OCT compound (Miles Inc., Elkhart, NI, USA), frozen and 30 μm thick sections were cut in a cryostat at −20°C. After rinsing in 0.1 M PBS, free-floating slices selected from −0.92 to −5.20 mm (from Bregma), i.e., where the orexinergic neurons are localized, were processed immunocytochemically.

Immunocytochemistry {#Sec5}
-------------------

The immunostaining was performed according to the ABC (avidin--biotin--horseradish peroxidase) method (Hsu et al. [@CR15]). Briefly, the endogenous peroxidase was inactivated with hydrogen peroxide (0.3% in methanol/PBS for 30 min), and the background was blocked with 5% normal goat serum (NGS) and 1% bovine serum albumin (BSA) in 0.5% Triton X-100. Appropriate rinsing in PBS followed these and subsequent procedures. Incubation in the primary antibodies (rabbit anti-Orexin A IgG, Calbiochem, Merck Chemicals, Nottingham, dilution 1:500; goat anti-OR1, 1:200, AbD Serotec, Oxford, UK; mouse anti-synaptophysin, 1:800, Abcam, Cambridge, UK; rabbit anti-MAP2, 1:200, and rabbit anti-GFAP, 1:750, both Abcam) was for 20 h at room temperature (RT), followed by treatment for 2 h with biotinilated secondary antibodies (goat anti-rabbit, donkey anti-mouse, donkey anti-goat IgG (1:500); Jackson ImmunoResearch, West Grove, PA, USA). After rinsing, the cell cultures and brain slices were incubated for 1 h in ABC complex (Vector Labs, Burlingame, CA, USA, 6.25 μl/ml of each compound in PBS). The peroxidase activity was visualized using 2.4% SG substrate kit (Vector) in PBS for 5 min at room temperature. The specimens were counterstained with 0.5% Neutral red (Sigma, St. Louis, MO, USA). Finally, the cultures and the brain slices were dehydrated in alcohol, cleared in xylene and coverslipped with Entellan (Merck, Darmstadt, Germany).

Negative controls included incubation at 4°C for 24 h after antigen--antibody preabsorption with the native antigen OXA (Calbiochem, Merck Chemicals, Nottingham), and replacement of the other primary antibodies with normal serum.

Data Analysis and Photomicrograph Production {#Sec6}
--------------------------------------------

Seven culturing experiments were made; eight to ten brains were used for each experiment. The dissociated cells were plated on 120 coverslips per experiment. We semi quantitatively graded the level of OXA expression in the neurons according to Ljungdahl et al. ([@CR21]), using the following four-point intensity scale: (−) background intensity of staining; (+) low intensity; (++) moderate intensity; (+++) high intensity. The images were generated through 10×, 20×, 40×, and 60× objectives and the cultures and brain slices were photographed with a Nikon DS-F*i*1 digital camera linked to a Nikon Eclipse 50*i* microscope. All digital images were matched for brightness in Adobe Photoshop 7.0 software. Cell counts for OXA expression were performed on five randomly chosen coverslips per age group. Statistical computations were performed using the StatView package for Windows, v 4.53 (Abacus Concepts Inc., Berkeley, California, USA). The analysis showed that data distribution is not normal, therefore we used the non-parametrical Mann--Whitney and Kruskal--Wallis tests for statistical comparison. For quantitative analysis of synaptic marker expression we counted the number of granules of reaction product after the synaptophysin staining. In each culture we calculated the granule density under a high magnification at seven different randomly chosen locations. We used Nikon NIS-Elements software, and obtained estimates of the mean densities per μm^2^ and standard deviations. We used two-way ANOVA to assess the statistical significance of density differences. Known sources of variation were control vs. OXA treated cultures and culture age. All data were presented as the mean ± SD (standard deviation). A *P* value smaller than 0.05 was considered statistically significant.

Results {#Sec7}
=======

Specificity {#Sec8}
-----------

The immunoreactivity was readily discernible by the presence of a dark-gray immunoreactive product. Neuronal structures were considered to be immunopositive when their staining was stronger than that in the background. In the brain slices OXA-positive cell bodies were found bilaterally, confined to the lateral hypothalamus at the level of the median eminence (Fig. [1](#Fig1){ref-type="fig"}a, b). There were no neurons in the brain cortex expressing OXA. We saw no immunoreactivity for OXA, OR1 or synaptophysin in the controls after preabsorption of the antibody with the antigen or its replacement with normal serum at the same concentration.Fig. 1Coronal section through the hypothalamus of an adult rat labeled with OXA antiserum. **a** Low magnification showing OXA-positive neurons distributed bilaterally in the lateral hypothalamus (*dark cells*). **b** Higher magnification of OXA-positive neurons in the perifornical area. Fornix (*F*). *Scale bars*: (**a**) 200 μm; (**b**) 50 μm

Identification of Neuronal and Glial Cells in the Cultures {#Sec9}
----------------------------------------------------------

In order to exclude the opportunity for OXA to be expressed by glial cells we applied immunostaining for neuronal and glial markers MAP2 and GFAP, respectively. In 1-day-old cultures it was hard to morphologically discriminate neurons from glial cells, but immunolabeling for GFAP indicated a very low fraction of glial cells. After one or more weeks of culturing, glial cells were well developed and none of the OXA-labeled cells had their morphology. In contrast, immunostaining for MAP2 and OXA clearly showed the same morphology of the labeled cells, i.e., only neurons were OXA-positive (data not shown).

Expression of OXA-, OR1- and Synaptophysin-Immunoreactivity {#Sec10}
-----------------------------------------------------------

Immunolabeling revealed that 91 ± 8% of the neurons in 1-day-old cultures were OXA-immunoreactive (IR). The reaction product was not uniformly distributed throughout the cytoplasm, but was sometimes concentrated in a restricted area of the perikaryon (Fig. [2](#Fig2){ref-type="fig"}a). The size of the neuronal cell bodies was small and the arborizations were shorter and thinner.Fig. 2**a** 1-Day-old culture processed for OXA detection. The neurons are underdeveloped, and most of them exhibit OXA-IR as dark granules, which are not dispersed in the entire cytoplasm. **b** OXA expression in 1-week-old culture. IR varies from negative, mainly in the large-sized perikarya, to highly intensive in the medium- to small-sized neurons. **c** Two-week-old culture. Cells and outgrowths are well developed. The *thick arrow* indicates a spindle-shaped neuron exhibiting high intensity of OXA-staining. The *double arrow* is pointing to a pyramidal perikaryon, which is OXA-negative. **d** Moderate intensity of OXA-labeling of neuronal somata (*arrows*) in a 3-week-old culture. **e** Four-week-old culture. Two OXA-positive multipolar neurons (*arrows*) with thick non-varicose processes forming a solid network. **f** Histogram of the OXA expression after subsequent DIV. *Scale bars*: (**a**, **c**, **e**) 30 μm; (**b**, **d**) 50 μm

In cultures grown for 1 week (Fig. [2](#Fig2){ref-type="fig"}b), a significantly lower fraction of all neurons (83 ± 13%, *P* = 0.03) were OXA-IR. The majority of orexinergic neurons were small, with fine bipolar or tufted dendrites, but some medium- to large-sized cells with basket-like morphology were also observed. The immunoreactivity was evenly distributed throughout the cell soma, excluding the nucleus.

In two-week-old cultures the proportion of OXA-IR neurons was 49 ± 18%, significantly lower than in 1-day- and 1-week-old cultures (*P* \< 0.0001). The neurons were already well developed and the orexinergic population consisted of two well distinguishable types of cells: spindle-shaped neurons and multipolar, pyramidal neurons. The intensity of immunostaining varied from (−), mainly in the large-sized perikarya, to (+), (++), and (+++) in the medium- to small-sized neurons of both multipolar and bipolar types (Fig. [2](#Fig2){ref-type="fig"}c). After 3 weeks' of growth (Fig. [2](#Fig2){ref-type="fig"}d), the clusters of neurons became very dense and the percentage of OXA-expressing neurons was 32 ± 19%. In 4-week-old cultures (Fig. [2](#Fig2){ref-type="fig"}e) the fraction of orexinergic neurons was not changed significantly: 33 ± 21% as summarized in Fig. [2](#Fig2){ref-type="fig"}f.

Figure [3](#Fig3){ref-type="fig"} shows the time course of expression of OR1-IR in cultures between 1 day and 4 weeks in vitro. After 1 day in vitro, neurons already demonstrated some initial expression of OR1 peptide (Fig. [3](#Fig3){ref-type="fig"}a). After 1 week, the immunoreactivity was more prominent and expressed in almost all neurons (Fig. [3](#Fig3){ref-type="fig"}b). When neurons were cultured for two or more weeks, the immunoreaction product was clearly discernible not only on the perikarya but also along the neurites (Fig. [3](#Fig3){ref-type="fig"}c, d).Fig. 3**a** Neurons cultured for 1 day expressing some IR for OR1, mainly on the cell bodies. **b** Well developed neuronal network after 1 (**b**), 2 (**c**), and 4 (**d**) weeks in vitro. Most of the neurons express OR1, and the reaction product is dispersed also along the neuronal arborizations. *Scale bars*: (**a**--**c**) 30 μm; (**d**) 50 μm

Chronic treatment of the cultures with medium supplemented with 2 μM OXA resulted in significant changes in synaptic development. As early as 4 days after OXA application, the neurons already showed some expression of synaptophysin (Fig. [4](#Fig4){ref-type="fig"}a), while the control cultures were immunonegative (Fig. [4](#Fig4){ref-type="fig"}b). After 2 weeks of incubation, the synaptophysin staining was much more abundant in conditioned cultures than in controls (Fig. [4](#Fig4){ref-type="fig"}c, d). Not only were the cell bodies immunolabeled, but the reaction product was also found along the neuronal arborizations. Three-week-old cultures were already well developed and equipped with synaptic contacts but comparison with controls showed substantial differences in synaptophysin expression (Fig. [4](#Fig4){ref-type="fig"}e, f). Figure [5](#Fig5){ref-type="fig"} depicts the development of the synaptic density in control cultures and OXA treated cultures. Two-way ANOVA showed that the synaptophysin granule density increased significantly with age in all cultures (*P* = 0.0005) and that the OXA conditioned networks had a significantly higher density of synaptophysin granules than the controls (*P* = 1.5 × 10^−6^).Fig. 4Immunolabeling for synaptophysin after chronic application of OXA and in the control sister cultures at age of 4 days (**a**, **b**), 2 weeks (**c**, **d**), and 3 weeks (**e**, **f**). The OXA conditioned cultures show a much higher expression of synaptophysin, earlier onset and sustained increase beyond 2 weeks in vitro compared to the controls. The panels in **e** and **f** show a closer view of fragments of synaptophysin-positive neurons. Notice the higher synaptic density in OXA treated culture. *Scale bars*: (**a**, **b**, **e**, **f**) 20 μm; (**c**, **d**) 30 μmFig. 5Development of the number of synaptophysin reactive granules per μm^2^ in control cultures and cultures chronically treated with orexin A during the first 3 weeks of development. All values are shown as mean ± SEM. The granule density depended significantly on the cultures age, and this density was significantly higher in OXA treated cultures

Discussion {#Sec11}
==========

This study demonstrates for the first time OXA expression in cultured dissociated cortical neurons. As is well-known, OXA is produced only by hypothalamic neurons and cortical neurons normally do not synthesize it in vivo neither in adult nor in newborn rats (Stoyanova et al. [@CR34]). However, in this study, we found that isolated cortical neurons did produce OXA, which suggests a conditioning-related change of phenotype. The initially high level of OXA expression decreased in the next 3--4 weeks of culturing, in close synchrony to the onset and subsequent increase of bioelectric activity.

Although neurotransmitters are generally associated with neuronal communication in the mature brain, many of them have been shown to influence several aspects of brain development and maturation (Levitt et al. [@CR19]). The synthesis de novo of OXA in isolated neuronal cultures, which we demonstrated here, may suggest some role for OXA as a signaling molecule for network development as it has been previously revealed for GABA and glutamate (Spoerri [@CR31]; Ben-Ari et al. [@CR1]). The orexin system develops very early in vivo (Van den Pol et al. [@CR37]; Stoyanova et al. [@CR34]); therefore the early expression of OR1 which we observed already at 1 DIV could be another indication for the importance of orexinergic input in developing networks. This observation is in accordance with the findings that the human sleep disorder, narcolepsy, as well as different neurodegenerative diseases, were recently related to a massive reduction or deficit of orexins and their receptors and a decreased level of OXA in the cerebrospinal fluid (Cui et al. [@CR6]; Friedman et al. [@CR10]; Petersén et al. [@CR25]; Ripley et al. [@CR26]). Experiments with transient common carotid artery occlusion in mice demonstrated increased levels of OXA and OR1 after ischemia (Nakamachi et al. [@CR23]). In addition, in orexin gene deficient mice permanent focal ischemia led to neuronal cell death, clearly showing the neuroprotective role of OXA and OR1 (Nakamachi et al. [@CR23]).

Cortical cultures in vitro are deprived from orexinergic input, which they normally receive in the brain in vivo. The high expression levels of OXA suggest that cortical cultures may homeostatically switch to the production of OXA as an adaptation mechanism to the isolated environment. A similar phenomenon has been recently described by Corner ([@CR3]), who showed that chronic blockade of either NMDA or AMPA glutamate receptors in organotypic neocortical slices resulted in activation of the other receptor, which maintained spontaneous (bursting) activity of the network. As sufficient activity is vital for their survival (De Marco García et al. [@CR8]), blocking both glutamate receptors would eliminate all activity and cultures would die. However, kainite receptor-mediated bursting takes over from both of the blocked excitatory receptor-types instead (Corner et al. [@CR5]). When kainite receptors were also blocked, bursts were restored partially because of cholinergic synaptic drive, which cortical neurons normally do not utilize (Corner [@CR4]). In other words, the developing network is so flexible that it homeostatically switches to another regulatory system or even to another neuronal phenotype in order to survive.

As has been shown, the first 2 weeks after plating are crucial for network formation and survival (Van Pelt et al. [@CR41]). Two major events during this period of time play a significant role in neuronal development: formation of synaptically connected networks, regulated by neurotropic and neurotrophic factors, and the emergence of bioelectrical network-wide activity patterns. In order to survive the axons must have established anatomical and functional connections by day 14 in vitro (Voigt et al. [@CR42]). This neuronal activity follows neural induction (in vivo) and precedes synapse formation (Spitzer [@CR30]). The activity dependence of synapse formation and neuronal survival at later stages of development has been recognized for some time (Zito and Svoboda [@CR43]). Thus, a rapid synapse formation begins during the first week in vitro, and reaches its maximum around day 21 (Ichikawa et al. [@CR16]), as does the activity of the network (Van Pelt et al. [@CR41]; Chiappalone et al. [@CR2]). This qualitatively mimics the in vivo time course of brain development (Romijn et al. [@CR27]), and perfectly coincides with the appearance of the orexin-positive structures in the brain during early postnatal stages (Stoyanova et al. [@CR34]), suggesting that OXA may play a role in synaptogenesis. Indeed, the results from our experiments with chronic application of OXA to cultured neurons for the first time demonstrate that OXA application has a stimulating effect on synaptogenesis and leads to its early onset.

Thus, in contrast to the in vivo cortex, cortical cultures experience a complete absence of neuronal input. At early developmental stages there is also very little internal activity in cultured networks (see Fig. [2](#Fig2){ref-type="fig"}g). However, ongoing activity is crucial for network vitality. The high OXA expression may be a homeostatic reaction to up regulate neuronal activity in isolated cultures. This up regulation may be twofold: OXA has a direct excitatory effect on cortical neurons and synaptogenesis is accelerated. It is yet not clear how these mechanisms interact.

Findings by van Huizen et al. suggested that synaptogenesis may be related to network activity. They achieved accelerated maturation in networks chronically disinhibited by picrotoxin (van Huizen et al. [@CR40]), whereas, classical experiments with tetradotoxin (TTX) blockade of spontaneous neuronal activity in fetal rat neocortex resulted in increased neural outgrowth and retarded synaptogenesis (van Huizen and Romijn [@CR39]).

Electron microscopic investigation of synaptic development in cultured cortical cells of rats showed a decrease in the synaptic density after 14 DIV (Ichikawa et al. [@CR16]). We observed a stabilization of synaptic density around that age in the controls in our study, whereas the density of synaptophysin expression gradually and significantly increased up to 21 DIV in OXA conditioned medium. The fact that the percentage of OXA-positive neurons in our study shows a maturational decrease over the incubation period, reaching its plateau of 32.5% during the third week in vitro, could be explained by a role as initial stimulator of synaptogenesis required for establishment of functional connections and survival of the network.

Our hypothesis that OXA is important in network formation is further supported by the results of studies by Van den Pol et al. and Li et al., who showed that orexinergic neurons in the hypothalamus are mainly innervated by excitatory glutamatergic synapses (Van den Pol et al. [@CR38], [@CR37]), and have a unique synaptic architecture: they are driven by glutamatergic inputs from local neurons that are utilized by orexinergic neurons to form positive feedback circuits onto themselves (Li et al. [@CR20]). Thus, at the early stages of network development, when excitatory input is crucial (Mennerick and Zorumski [@CR22]; De Marco García et al. [@CR8]), the neurons are able to establish regulatory loops for self-stimulation (and thus survival) via onset of OXA synthesis. Because of the strong mutual influences between neuronal connectivity and activity, and the development of connectivity, already shown at network level (le Feber et al. [@CR17], [@CR18]), further electrophysiological experiments may functionally validate the effects of OXA on the network activity.

In summary, dissociated postnatal cortical neurons of the rat express OXA, which could be regarded as a form of homeostatic neuronal plasticity, an adaptation mechanism to a new environment. Our findings demonstrate for the first time that, in vitro, OXA stimulates synaptogenesis and thus neuronal interactions. This implies involvement of the neurotransmitter in network development and maturation during the early stages of culturing. Whether this effect is direct or exerted via different neurotrophic factors still remains to be elucidated.
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